These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1682043)

  • 1. Mutations in the p53 gene in primary human breast cancers.
    Osborne RJ; Merlo GR; Mitsudomi T; Venesio T; Liscia DS; Cappa AP; Chiba I; Takahashi T; Nau MM; Callahan R
    Cancer Res; 1991 Nov; 51(22):6194-8. PubMed ID: 1682043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH; Bayona W; Koslow M; Newcomb EW
    Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
    Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
    Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.
    McKenzie KE; Siva A; Maier S; Runnebaum IB; Seshadri R; Sukumar S
    Clin Cancer Res; 1997 Sep; 3(9):1669-73. PubMed ID: 9815858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
    Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Saito S; Itakura M
    Cancer Res; 1992 Sep; 52(18):5061-4. PubMed ID: 1516062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
    Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
    Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of p53 mutations in bilateral breast carcinoma.
    Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ
    Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
    Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J; Thompson AM; Cranston G; Evans HJ
    Oncogene; 1990 Oct; 5(10):1573-9. PubMed ID: 2250913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
    Cote RJ; Jhanwar SC; Novick S; Pellicer A
    Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
    Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.